Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial. Issue 3 (14th February 2021)

• Record Type: Journal Article
• Authors: Tseng, Joshua; Alban, Rodrigo F.; Siegel, Emily; Chung, Alice; Giuliano, Armando E.; Amersi, Farin F.
• Is Part Of: Breast journal. Volume 27:Issue 3(2021)
• Page Start: 216
• Page End: 221
• Publication Date: 2021-02-14
• Subjects: ACOSOG Z0011 -- axillary lymph node dissection -- NCDB -- sentinel lymph node biopsy; Breast -- Diseases -- Periodicals; Breast -- Cancer -- Periodicals; 618.19
• DOI: 10.1111/tbj.14191
• Languages: English
• ISSNs: 1075-122X

Abstract

Abstract: The American College of Surgeons Oncology Group Z0011 (ACOSOG Z0011) trial demonstrated no survival advantage for women with clinical T1–T2 invasive breast cancer with 1–2 positive sentinel lymph nodes (SLN) who received whole‐breast radiation, and no further axillary surgery when compared to women who did undergo axillary lymph node dissection (ALND). We used the National Cancer Database (NCDB) to study changes in utilization of ALND after the publication of this trial. NCDB was queried for female patients from 2012 to 2015 who met Z0011 criteria. Patients were divided into four groups based on Commission on Cancer facility accreditation. Outcome measures include the rate of ALND (nonadherence to Z0011) and the average number of nodes retrieved with ALND. 27, 635 patients were identified, with no significant differences in T stage and receptor profiles between groups. Overall rate of ALND decreased from 34.0% in 2012 to 22.7% in 2015. Nonadherence was lowest in Academic Programs (decreasing from 30.1% in 2012 to 20.5% in 2015) and was highest in Community Cancer Programs (41.2% in 2012 to 29.1% in 2015). Median number of positive SLN did not differ between groups ( p = .563). Median number of nodes retrieved on ALND decreased from 9 (IQR 5–14) in 2012 to 7 (IQR 4–12) in 2015 ( p < .001). In patients who met the ACOSOG Z11 trial guidelines, rates of ALND have decreased over time. However, rates of nonadherence to Z0011 are significantly higher in Community Cancer Programs compared to Academic Programs.